⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Cognition Therapeutics, Inc. Common Stock

$0.7350
-0.0182 (-2.42%)

Market Capitalization:

$69.89M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Cognition Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

-0.0140(-1.87%)
Open$0.7490
Close$0.7350
Low$0.7350
Low Change-0.0140 (-1.87%)
High$0.7490
High Change+0.0000 (+0.00%)
Range$0.0140
Volume6.953K
Dollar Volume$5.11K

Regular Trading Hours Yesterday

-0.0151(-1.97%)
Open$0.7683
Close$0.7532
Low$0.7350
Low Change-0.0333 (-4.33%)
High$0.7835
High Change+0.0152 (+1.98%)
Range$0.0485
Volume335.071K
Dollar Volume$252.38K

Premarket Yesterday

-0.0062(-0.78%)
Open$0.7899
Close$0.7837
Low$0.7683
Low Change-0.0216 (-2.73%)
High$0.7900
High Change+0.0001 (+0.01%)
Range$0.0217
Volume2.437K
Dollar Volume$1.91K

Cognition Therapeutics Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Cognition Therapeutics Moving Averages

5 Day Moving Average (SMA5)$0.7270
10 Day Moving Average (SMA10)$0.7306
20 Day Moving Average (SMA20)$0.8075
50 Day Moving Average (SMA50)$0.9261
100 Day Moving Average (SMA100)$1.0071
200 Day Moving Average (SMA200)$1.0754

Cognition Therapeutics Statistics

Average Volume (30 Days)397.09K
P/E Ratio (Current)-4.89
EPS (Current)-$0.18
Dividend Yield0.00%
Free Cash Flow-$17.70M
Cash Ratio6.24
Current Ratio7.03
Quick Ratio7.03
Debt to Equity0.00
Enterprise Value$49.67M
EV to EBITDA-1.36
EV to Sales—
Price to Book2.53
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.43%
Return on Equity-0.51%

Cognition Therapeutics Stock Splits

There have been no stock splits for Cognition Therapeutics (CGTX).

Cognition Therapeutics Dividends

There have been no dividends for Cognition Therapeutics (CGTX).